These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33506447)

  • 1. Graves' Orbitopathy: Current Concepts for Medical Treatment.
    Oeverhaus M; Stöhr M; Möller L; Führer D; Eckstein A
    Klin Monbl Augenheilkd; 2021 Jan; 238(1):24-32. PubMed ID: 33506447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Graves' orbitopathy: Current concepts for medical treatment].
    Oeverhaus M; Stöhr M; Möller L; Führer D; Eckstein A
    Laryngorhinootologie; 2023 Mar; 102(3):177-185. PubMed ID: 36858060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Graves' orbitopathy].
    Eckstein A; Möller L; Führer D; Oeverhaus M
    Dtsch Med Wochenschr; 2021 Oct; 146(20):1344-1351. PubMed ID: 34644795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.
    Bartalena L; Kahaly GJ; Baldeschi L; Dayan CM; Eckstein A; Marcocci C; Marinò M; Vaidya B; Wiersinga WM;
    Eur J Endocrinol; 2021 Aug; 185(4):G43-G67. PubMed ID: 34297684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Graves' ophthalmopathy].
    Eckstein A; Esser J
    Internist (Berl); 2010 May; 51(5):584, 586-8, 590-2, passim. PubMed ID: 20383481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current concepts regarding Graves' orbitopathy.
    Bartalena L; Tanda ML
    J Intern Med; 2022 Nov; 292(5):692-716. PubMed ID: 35604323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Graves' orbitopathy].
    Eckstein A; Esser J
    Klin Monbl Augenheilkd; 2011 May; 228(5):432-8. PubMed ID: 21534176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial.
    Kahaly GJ; Riedl M; König J; Pitz S; Ponto K; Diana T; Kampmann E; Kolbe E; Eckstein A; Moeller LC; Führer D; Salvi M; Curro N; Campi I; Covelli D; Leo M; Marinò M; Menconi F; Marcocci C; Bartalena L; Perros P; Wiersinga WM;
    Lancet Diabetes Endocrinol; 2018 Apr; 6(4):287-298. PubMed ID: 29396246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sight-threatening Graves' orbitopathy: Twenty years' experience of a multidisciplinary thyroid-eye outpatient clinic.
    Tramunt B; Imbert P; Grunenwald S; Boutault F; Caron P
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):208-213. PubMed ID: 30339291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive score.
    Watanabe N; Yoshimura Noh J; Kozaki A; Yoshimura R; Yoshihara A; Suzuki N; Matsumoto M; Fukushita M; Kinoshita A; Aida A; Imai H; Hiruma S; Inoue T; Inoue K; Sugino K; Ito K
    Endocr J; 2023 Nov; 70(11):1087-1096. PubMed ID: 37743517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Graves ophthalmopathy - 2022 update.
    Jiskra J
    Cas Lek Cesk; 2022; 161(5):198-206. PubMed ID: 36443100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.
    Bartalena L; Baldeschi L; Boboridis K; Eckstein A; Kahaly GJ; Marcocci C; Perros P; Salvi M; Wiersinga WM;
    Eur Thyroid J; 2016 Mar; 5(1):9-26. PubMed ID: 27099835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graves' ophthalmopathy].
    Eckstein A; Dekowski D; Führer-Sakel D; Berchner-Pfannschmidt U; Esser J
    Ophthalmologe; 2016 Apr; 113(4):349-64; quiz 465-6. PubMed ID: 27059986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy.
    Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D
    J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-Dose Rituximab for Active Moderate to Severe Graves' Orbitopathy Resistant to Conventional Treatment.
    Du Pasquier-Fediaevsky L; Andrei S; Berche M; Leenhardt L; Héron E; Rivière S
    Ocul Immunol Inflamm; 2019; 27(5):844-850. PubMed ID: 29652204
    [No Abstract]   [Full Text] [Related]  

  • 16. Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.
    Perros P; Hegedüs L; Bartalena L; Marcocci C; Kahaly GJ; Baldeschi L; Salvi M; Lazarus JH; Eckstein A; Pitz S; Boboridis K; Anagnostis P; Ayvaz G; Boschi A; Brix TH; Currò N; Konuk O; Marinò M; Mitchell AL; Stankovic B; Törüner FB; von Arx G; Zarković M; Wiersinga WM
    Orphanet J Rare Dis; 2017 Apr; 12(1):72. PubMed ID: 28427469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
    Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update on endocrine orbitopathy].
    Eckstein A; Berchner-Pfannschmidt U; Führer D; Esser J
    Ophthalmologe; 2013 Nov; 110(11):1079-96. PubMed ID: 24231915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Knowledge on Graves' Orbitopathy.
    Gontarz-Nowak K; Szychlińska M; Matuszewski W; Stefanowicz-Rutkowska M; Bandurska-Stankiewicz E
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33374706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
    Wiersinga WM
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.